These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8357529)

  • 1. Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement.
    Phillips GD; Le Noury J; Wolterink G; Donselaar-Wolterink I; Robbins TW; Everitt BJ
    Behav Brain Res; 1993 Jun; 55(2):223-31. PubMed ID: 8357529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intra-amygdala R(+) 7-OH-DPAT on intra-accumbens d-amphetamine-associated learning. II. Instrumental conditioning.
    Hitchcott PK; Phillips GD
    Psychopharmacology (Berl); 1998 Dec; 140(3):310-8. PubMed ID: 9877011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer.
    Phillips GD; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 1994 Mar; 114(2):345-59. PubMed ID: 7838928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine.
    Burns LH; Robbins TW; Everitt BJ
    Behav Brain Res; 1993 Jun; 55(2):167-83. PubMed ID: 8357526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum.
    Cador M; Robbins TW; Everitt BJ
    Neuroscience; 1989; 30(1):77-86. PubMed ID: 2664556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced responding for conditioned reward produced by intra-accumbens amphetamine is potentiated after cocaine sensitization.
    Taylor JR; Horger BA
    Psychopharmacology (Berl); 1999 Feb; 142(1):31-40. PubMed ID: 10102780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine.
    Taylor JR; Robbins TW
    Psychopharmacology (Berl); 1986; 90(3):390-7. PubMed ID: 3097729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation rearing impairs the reinforcing efficacy of intravenous cocaine or intra-accumbens d-amphetamine: impaired response to intra-accumbens D1 and D2/D3 dopamine receptor antagonists.
    Phillips GD; Howes SR; Whitelaw RB; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 1994 Jul; 115(3):419-29. PubMed ID: 7871084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine.
    Parkinson JA; Olmstead MC; Burns LH; Robbins TW; Everitt BJ
    J Neurosci; 1999 Mar; 19(6):2401-11. PubMed ID: 10066290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens.
    Taylor JR; Robbins TW
    Psychopharmacology (Berl); 1984; 84(3):405-12. PubMed ID: 6440188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine and conditioned reinforcement. II. Contrasting effects of amphetamine microinjection into the nucleus accumbens with peptide microinjection into the ventral tegmental area.
    Kelley AE; Delfs JM
    Psychopharmacology (Berl); 1991; 103(2):197-203. PubMed ID: 1709289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of ondansetron and alpha-flupenthixol on responding for conditioned reward.
    Fletcher PJ; Higgins GA
    Psychopharmacology (Berl); 1997 Nov; 134(1):64-72. PubMed ID: 9399368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Devazepide, a CCKA receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity.
    Josselyn SA; Franco VP; Vaccarino FJ
    Psychopharmacology (Berl); 1996 Jan; 123(2):131-43. PubMed ID: 8741936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of 5-HT1B receptors in the nucleus accumbens reduces amphetamine-induced enhancement of responding for conditioned reward.
    Fletcher PJ; Korth KM
    Psychopharmacology (Berl); 1999 Feb; 142(2):165-74. PubMed ID: 10102769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sensitivity to amphetamine and reward-related stimuli following social isolation in rats: possible disruption of dopamine-dependent mechanisms of the nucleus accumbens.
    Jones GH; Marsden CA; Robbins TW
    Psychopharmacology (Berl); 1990; 102(3):364-72. PubMed ID: 2251333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of conditioned reward blocked by intra-accumbens infusion of PD-140548, a CCKA receptor antagonist.
    Josselyn SA; Vaccarino FJ
    Pharmacol Biochem Behav; 1996 Nov; 55(3):439-44. PubMed ID: 8951986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of excitotoxic lesions of the central amygdaloid nucleus on the potentiation of reward-related stimuli by intra-accumbens amphetamine.
    Robledo P; Robbins TW; Everitt BJ
    Behav Neurosci; 1996 Oct; 110(5):981-90. PubMed ID: 8919000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intra-amygdala R(+) 7-OH-DPAT on intra-accumbens d-amphetamine-associated learning. I. Pavlovian conditioning.
    Hitchcott PK; Phillips GD
    Psychopharmacology (Berl); 1998 Dec; 140(3):300-9. PubMed ID: 9877010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-accumbens amphetamine increases the conditioned incentive salience of sucrose reward: enhancement of reward "wanting" without enhanced "liking" or response reinforcement.
    Wyvell CL; Berridge KC
    J Neurosci; 2000 Nov; 20(21):8122-30. PubMed ID: 11050134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
    Crawley JN
    J Neurosci; 1992 Sep; 12(9):3380-91. PubMed ID: 1527584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.